Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Mueller

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|March 7, 2022
High PIRCHE Scores May Allow Risk Stratification of Borderline Rejection in Kidney Transplant RecipientsEkaterina Lezoeva, Jakob Nilsson, Rudolf Wüthrich, et al.
Expert Review of Molecular Diagnostics|March 17, 2011
Identifying biomarkers as diagnostic tools in kidney transplantationValeria R Mas, Thomas F Mueller, Kellie J Archer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 19, 2021
Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathyBettina Naef, Jakob Nilsson, Rudolf P Wuethrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profilesKenneth Christopher, Thomas F Mueller, Chunyan Ma, et al.
Pediatric Nephrology (Berlin, Germany)|December 6, 2023
Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic reviewPaul L de Zwart, Thomas F Mueller, Giuseppina Spartà, et al.
European Journal of Clinical Pharmacology|January 30, 2019
Severe reduction in tacrolimus concentrations with concomitant metamizole (dipyrone) therapy in transplant patientsAli Sigaroudi, Alexander Jetter, Thomas F Mueller, et al.
Human Immunology|November 9, 2020
HLA antibodies are associated with deterioration of kidney allograft function irrespective of donor specificitySeraina von Moos, Pietro E Cippà, Rob van Breemen, et al.
BMC Nephrology|November 24, 2020
Tailored immunosuppression after kidney transplantation - a single center real-life experienceMiriam Good-Weber, Malgorzata Roos, Thomas F Mueller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2024
Facts and myths about altruistic organ donationMehmet Sukru Sever, Thomas F Mueller, Gabriel C Oniscu, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 17, 2022
Entering the Third Decade After Kidney Transplantation: Excellent Graft Function Refers to Superior Graft but Not Patient SurvivalAnna Vera Reimann, Jakob Nilsson, Rudolf P Wuethrich, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|March 7, 2022
High PIRCHE Scores May Allow Risk Stratification of Borderline Rejection in Kidney Transplant RecipientsEkaterina Lezoeva, Jakob Nilsson, Rudolf Wüthrich, et al.
Expert Review of Molecular Diagnostics|March 17, 2011
Identifying biomarkers as diagnostic tools in kidney transplantationValeria R Mas, Thomas F Mueller, Kellie J Archer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 19, 2021
Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathyBettina Naef, Jakob Nilsson, Rudolf P Wuethrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profilesKenneth Christopher, Thomas F Mueller, Chunyan Ma, et al.
Pediatric Nephrology (Berlin, Germany)|December 6, 2023
Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic reviewPaul L de Zwart, Thomas F Mueller, Giuseppina Spartà, et al.
European Journal of Clinical Pharmacology|January 30, 2019
Severe reduction in tacrolimus concentrations with concomitant metamizole (dipyrone) therapy in transplant patientsAli Sigaroudi, Alexander Jetter, Thomas F Mueller, et al.
Human Immunology|November 9, 2020
HLA antibodies are associated with deterioration of kidney allograft function irrespective of donor specificitySeraina von Moos, Pietro E Cippà, Rob van Breemen, et al.
BMC Nephrology|November 24, 2020
Tailored immunosuppression after kidney transplantation - a single center real-life experienceMiriam Good-Weber, Malgorzata Roos, Thomas F Mueller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2024
Facts and myths about altruistic organ donationMehmet Sukru Sever, Thomas F Mueller, Gabriel C Oniscu, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 17, 2022
Entering the Third Decade After Kidney Transplantation: Excellent Graft Function Refers to Superior Graft but Not Patient SurvivalAnna Vera Reimann, Jakob Nilsson, Rudolf P Wuethrich, et al.
Pageof 8